ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

Investigational Site (115), Manhasset

Investigational Site (175), Brooklyn

Investigational Site (149), Marseille

Investigational Site (137), A Coruña

Investigational Site (179), Charlotte

Investigational Site (152), Ormond Beach

Investigational Site (106), DeBary

Investigational Site (120), Hialeah

Investigational Sites (134), Miami

Investigational Site (190), Tamarac

Investigational Site (133), Plantation

Investigational Site (163), Tampa

Investigational Site (107), Anniston

Investigational Site (186), Memphis

Investigational Site (112), Crossville

Investigational Site (139), Seville

Investigational Site (138), Grand Blanc

Investigational Site (156), Skokie

Investigational Site (104), Mesquite

Investigational Site (118), Colleyville

Investigational Site (166), Fort Worth

Investigational Site (121), Houston

Investigational Site (143), Bellaire

Investigational Site (171), Baytown

Investigational Site (162), San Antonio

Investigational Site (127), San Antonio

Investigational Site (173), Idaho Falls

Investigational Site (189), Phoenix

Investigational Site (164), Las Vegas

Investigational Site (155), Los Angeles

Investigational Site (109), San Diego

Investigational Site (169), Santa Barbara

Investigational Site (128), Paris

Investigational Site (161), Paris

Investigational Site (181), Budapest

Investigational Site (180), Gyula

Investigational Site (183), Székesfehérvár

Investigational Site (160), Elblag

Investigational Site (184), Taichung

Investigational Site (182), Taipei

Investigational Site (110), Krakow

Investigational Site (108), Poznan

Investigational Site (119), Poznan

Investigational Site (165), Wroclaw

Investigational Site (191), Caguas

Investigational Site (187), San Juan